免疫检查点封锁导致原发性和转移性脑瘤微环境的明显变化
Lu Sun1, Jenny C Kienzler1,2, Jeremy G Reynoso1
1Department of Neurosurgery, UCLA, Los Angeles, California, USA.
The Journal of clinical investigation
|September 1, 2023
概括
免疫检查点阻塞 (ICB) 疗法在脑转移 (BrM) 中增加了T细胞透,比在复发性质母细胞瘤 (rGBM) 中更多. 这种疗法还减少了特定的巨细胞,可能改善T细胞的进入和患者的存活率.
科学领域:
- 神经瘤学神经瘤学
- 免疫治疗是一种免疫疗法.
- 翻译研究是翻译研究.
背景情况:
- 大脑转移 (BrM) 对免疫检查点阻塞 (ICB) 的内反应比复发性质母细胞瘤 (rGBM) 了解得更少.
- 了解BrM免疫微环境对于优化ICB疗效至关重要.
研究的目的:
- 为了比较brm和rgbm在对icb的反应中的免疫细胞格局.
- 确定影响T细胞透和ICB治疗的BrM患者的患者存活率的机制.
主要方法:
- 综合单细胞RNA-Seq (scRNA-Seq) 分析ICB原始和ICB处理的BrM样本.
- 与rGBM的scRNA-Seq数据进行比较.
- 多重复合免疫光学和空间转录组学用于分析巨细胞群和空间结构.
主要成果:
- 与rGBM相比,ICB诱导了更多的T细胞透到BrM中.
- M透的T细胞显示出瘤特异性,激活/耗尽的表型.
- ICB在周血管空间减少了CD206+巨细胞,可能有助于T细胞进入.
- 一个原始耗尽的T细胞子集与BrM患者的整体存活率的改善相关.
结论:
- ICB重塑了BrM的免疫微环境,增强了T细胞的透.
- 针对特定的巨细胞群体可能会提高ICB在脑瘤中的有效性.
- 预后性T细胞子集的识别为BrM提供了潜在的治疗策略.
相关概念视频
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:30Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K